These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2249235)

  • 1. [Use of flow cytometry in the determination of HLA antigens].
    Prazák J; Vanĕk S
    Cas Lek Cesk; 1990 Oct; 129(43):1365-8. PubMed ID: 2249235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The HLA crossmatching test before thrombocyte transfusion. Comparison of 3 methods].
    Májský A; Prazák J
    Vnitr Lek; 1990 Sep; 36(9):873-8. PubMed ID: 2251774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytotoxic antiglobulin test--a sensitive method for HLA typing].
    Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):655-63. PubMed ID: 6184290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT).
    Neumüller J; Schwartz DW; Dauber E; Mayr WR
    Cytometry; 1996 Sep; 26(3):209-15. PubMed ID: 8889393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standardization and automation of HLA B27 typing by flow cytometry: validation and comparison with microlymphocytotoxicity].
    Monneret G; Seffert O; Debard AL; Gutowski MC; Couprie N; Larbre JP; Tebib J; Bienvenu J
    Ann Biol Clin (Paris); 2000; 58(4):461-6. PubMed ID: 10932047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is the fluorescence cytotoxicity test for the determination of HLA-DR antigens more sensitive than the classical microcytotoxicity test?].
    Prazák J; Májský A
    Cas Lek Cesk; 1989 Aug; 128(33):1047-9. PubMed ID: 2790911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossmatching on platelets by flow cytometry.
    Wang GX; Terashita GY; Terasaki PI
    Clin Transpl; 1988; ():381-5. PubMed ID: 3154488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 typing by use of flow cytofluorometry.
    Albrecht J; Müller HA
    Clin Chem; 1987 Sep; 33(9):1619-23. PubMed ID: 3304714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation of the effect of human complement in the cytotoxic test to the origin of the HLA serum].
    Májský A
    Vnitr Lek; 1989 Nov; 35(11):1102-5. PubMed ID: 2483006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Luminex technology for HLA typing by PCR-SSO and identification of HLA antibody specificities].
    Cesbron-Gautier A; Simon P; Achard L; Cury S; Follea G; Bignon JD
    Ann Biol Clin (Paris); 2004; 62(1):93-8. PubMed ID: 15047498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
    LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
    Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.
    Saw CL; Bray RA; Gebel HM
    Cytometry B Clin Cytom; 2008 Sep; 74(5):287-94. PubMed ID: 18454488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test.
    Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vítko S; Valhová S; Stríz I; Ivasková E
    Transpl Int; 2003 Dec; 16(12):872-8. PubMed ID: 12904845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiglobulin cytotoxic test. A study of factors responsible for non-specificity of reaction (author's transl)].
    Májský A
    Cas Lek Cesk; 1981 Jun; 120(25):764-9. PubMed ID: 6973395
    [No Abstract]   [Full Text] [Related]  

  • 17. [Microlymphocytotoxic test with T lymphocytes: positivity by 3 hrs incubation (author's transl)].
    Májský A
    Allerg Immunol (Leipz); 1978; 24(4):294-8. PubMed ID: 154291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of reactivity of HLA-Cw antisera by extending the incubation time.
    Wong DM; Kumar R; Mittal KK
    Acta Anthropogenet; 1983; 7(3):197-203. PubMed ID: 6335043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA typing strategies in a cord blood bank.
    Laurenti L; Perrone MP; Bafti MS; Ferrari F; Screnci M; Pasqua I; Girelli G
    Haematologica; 2002 Aug; 87(8):851-4. PubMed ID: 12161362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation.
    Schumm M; Feuchtinger T; Pfeiffer M; Hoelle W; Bethge W; Ebinger M; Kuci S; Handgretinger R; Lang P
    Bone Marrow Transplant; 2007 Jun; 39(12):767-73. PubMed ID: 17438586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.